Physician profile
Pradeep Atla
NPI 1649446543
$1,197.63
in general payments reported to CMS, 2019-2025
14 companies · $86.36 in 2025
The $86.36 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $179 · 2021: $134 · 2023: $34.27 · 2024: $309 · 2025: $86.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $383.03 | 2020-2025 | Exalt Model D, Axios, Advanix Biliary |
| Abbvie INC. | $271.32 | 2019-2025 | Rinvoq, Skyrizi |
| Cook Medical LLC | $114.14 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $82.27 | 2019-2021 | |
| Janssen Biotech, INC. | $66.03 | 2019-2021 | |
| Mauna Kea Technologies, INC. | $62.70 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.81 | 2019 | |
| Daiichi Sankyo INC. | $37.30 | 2020-2021 | |
| Pfizer INC. | $30.35 | 2019-2020 | |
| Evoke Pharma, INC. | $23.88 | 2021 | |
| Allergan, INC. | $21.70 | 2019 | |
| Ucb, INC. | $19.76 | 2020 | |
| Merck Sharp & Dohme LLC | $17.89 | 2020 | |
| Gilead Sciences, INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pradeep Atla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.